文档介绍：阿奇霉素联合头孢噻肟钠对慢性阻塞性肺疾病患者肺功能的影响
[摘要]目的 探討阿奇霉素联合头孢噻肟钠对慢性阻塞性肺疾病患者肺功能的影响。方法 选取2017年4月~2018年4月深圳市蛇口人民医院收治的100例慢性阻塞性肺疾病患者the clinical treatment effect were compared between the two groups. Results Before treatment, there were no significant differences in the forced vital capacity (FVC), maximum ventilator volume (MVV), and forced expiratory volume in 1 second (FEV1) between the two groups (P>). After treatment, the FVC of patients of the study group was (±) L, the MVV was (±) L/min, and the FEV1 was (±) L, which were higher than those in the control group ([±] L, [±] L/min, [±] L), the differences were statistically significant (P<). Before treatment, there were no statistically significant differences in the scores of chronic cough and expectoration, shortness of breath, wheezing chest tightness, and fatigue and weight loss between the two groups (P>). The score of chronic cough and expectoration after treatment was (±) points, the score of shortness of breath after treatment was (±) points, the score of wheezing chest tightness after treatment was (±) points, and the score of fatigue and weight loss after treatment was (±) points in the study group, all lower than those in the control group ([±], [±], [±], [±] points), the differences were statistically significant (P<). The total effective rate was % in the study group, which was higher than that in the control group accounting for % (P<). Conclusion The treatment of Azithromycin combined with Cefotaxime Sodium in patients with chronic obstructive pulmonary disease is more effective, can effectively improve the lung function index and symptom index, and has important clinical application value. [Key words] Azithromycin; Cefotaxime Sodium; Chronic obstructive pulmonary disease; Effect; Lung function
慢性阻塞性肺疾病为临床的常见疾病,其主要疾病特征为以气流阻塞为主的慢性支气管炎或以气流阻塞为主的肺气肿,均合并不同程度的气流阻塞情况